AZTR
Azitra Inc
NYSE MKT: AZTR · HEALTHCARE · BIOTECHNOLOGY
$0.25
+0.52% today
Updated 2026-04-29
Market cap
$3.56M
P/E ratio
—
P/S ratio
239.97x
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$0 – $2
Volume
14.7M
Azitra Inc (AZTR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $110000.00 | $284000.00 | $686000.00 | $7.50M | $0.00 |
| Revenue growth (YoY) | — | — | +158.2% | +141.5% | +993.3% | -100.0% |
| Cost of revenue | — | $84772.00 | $405977.00 | $425549.00 | $448235.00 | $453144.00 |
| Gross profit | — | $110000.00 | $284000.00 | $686000.00 | $7.50M | $-453144.00 |
| Gross margin | — | 100.0% | 100.0% | 100.0% | 100.0% | — |
| R&D | — | $5.38M | $6.10M | $3.64M | $4.72B | $4.84B |
| SG&A | — | $3.95M | $3.64M | $4.49M | $6.27B | $6.13B |
| Operating income | — | $-9.22M | $-9.45M | $-7.45M | $-10.99B | $-10.97M |
| Operating margin | — | -8383.1% | -3328.7% | -1086.1% | -146468.5% | — |
| EBITDA | — | $-8.79M | $-10.02M | $-10.67M | $-8.50M | $-10.49M |
| EBITDA margin | — | -7989.0% | -3529.0% | -1555.9% | -113.3% | — |
| EBIT | $-6.89M | $-8.87M | $-10.43M | $-11.10M | $-8.95M | $-10.94M |
| Interest expense | — | $66968.00 | $251891.00 | $167726.00 | $12160.00 | $7587.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | — | $-8.94M | $-10.68M | $-11.28M | $-8.97M | $-10.96M |
| Net income growth (YoY) | — | — | -19.5% | -5.6% | +20.5% | -22.2% |
| Profit margin | — | -8127.0% | -3760.7% | -1644.9% | -119.6% | — |